Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

July 17, 2019

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

July 16, 2019

Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry

May 29, 2019

Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

May 21, 2019

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

May 13, 2019

Anixa Biosciences to Present at B. Riley FBR Institutional Investor Conference

May 2, 2019

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

April 17, 2019

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

April 11, 2019

Anixa Biosciences Presents Cchek™ Prostate Cancer Detection Data at AACR Annual Meeting

April 3, 2019

Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy

March 27, 2019

RSS
  • « Previous
  • 1...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ...21
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Mar 13, 2023

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

Read More...
Mar 2, 2023

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

Read More...
Feb 27, 2023

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology

Read More...
Copyrights © 2023 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap